Get it on Google Play

Salix Pharmaceuticals (SLXP) Submits NDA to FDA for Balsalazide Tablet

July 17, 2007 1:16 PM EDT Send to a Friend
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) has submitted to the U.S. Food and Drug Administration (FDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login